Ruptured ovarian cysts are a common gynecological emergency presentation, most frequently involving functional (physiological) cysts, particularly the corpus luteum. The condition is generally self-limiting, with approximately 80–85% of cases managed conservatively; surgery is required in ~15–20% of cases, primarily for hemodynamic compromise or large hemoperitoneum. [1-2]
1. History
- Onset: Sudden-onset, sharp, unilateral lower abdominal/pelvic pain — often described as a "pop" or acute tearing sensation
- Timing: Frequently occurs mid-cycle (follicular cyst) or in the luteal phase (corpus luteum); may follow sexual intercourse, exercise, or straining, though no consistent trigger is identified [1]
- Severity: Ranges from mild discomfort to severe, incapacitating pain
- Associated symptoms: Nausea, vomiting, vaginal bleeding, lightheadedness/presyncope (if significant hemorrhage)
- Important negatives to elicit: Fever (argues against simple rupture), missed period or pregnancy possibility, history of IUD/contraception use, prior STI history, urinary symptoms, bowel changes
- Menstrual history: Last menstrual period, regularity, possibility of pregnancy [3]
2. Alarm Features
- Hemodynamic instability: Tachycardia, hypotension (SBP <90 mmHg), diastolic BP ≤70 mmHg — strongly predicts need for surgical intervention [2]
- Peritoneal signs: Diffuse rebound tenderness, guarding, rigidity
- Syncope or presyncope with acute pelvic pain
- Positive pregnancy test — must rule out ruptured ectopic pregnancy, which can cause fatal hemoperitoneum [4]
- Signs of hemorrhagic shock: Pallor, diaphoresis, altered mental status, tachypnea [5]
- Persistent or worsening pain despite analgesia
- Fever >38°C — raises concern for tubo-ovarian abscess or other infectious etiology [3]
3. Medications
- Relevant contributors:
- Anticoagulants (warfarin, DOACs, heparin) significantly increase risk of hemorrhagic ovarian cyst rupture and life-threatening hemoperitoneum; supratherapeutic INR is a major risk factor [6-8]
- Ovulation induction agents (clomiphene, gonadotropins) increase cyst formation and rupture risk [9]
- Acute treatment:
- NSAIDs (ketorolac 15–30 mg IV, ibuprofen 600–800 mg PO) — first-line analgesia
- Opioids (morphine, fentanyl) for severe pain refractory to NSAIDs
- IV fluids for volume resuscitation if hemodynamically compromised
- Antiemetics (ondansetron) as needed
- Prevention of recurrence:
- Combined oral contraceptives (COCs) suppress ovulation and prevent recurrent functional cyst rupture [10]
- In patients on anticoagulation, progestin-only methods (subdermal implant preferred, or depo-medroxyprogesterone, LNG-IUD) are first-line for ovulation suppression to prevent hemorrhagic cysts [6]
- Contraindicated: Avoid aspirin/NSAIDs in patients with active hemorrhage and hemodynamic instability; hold anticoagulants in acute hemorrhagic rupture [11]
4. Diet
- No specific dietary triggers for ovarian cyst rupture
- NPO status if surgical intervention is anticipated
- Adequate hydration during conservative management
- Long-term: No evidence-based dietary modifications to prevent recurrence
5. Review of Systems
- GI: Nausea, vomiting, anorexia, change in bowel habits (constipation/diarrhea may mimic GI pathology)
- GU: Dysuria, urinary frequency/urgency (to rule out UTI/nephrolithiasis), vaginal bleeding or discharge
- Reproductive: Missed period, dyspareunia, prior ovarian cyst history
- Constitutional: Fever, chills (infectious etiology), weight loss, bloating (malignancy)
- Cardiovascular: Lightheadedness, syncope, palpitations (hemorrhage)
6. Collateral History and Family History
- Collateral: Confirm timing of symptom onset, any witnessed syncope, medication compliance (especially anticoagulants)
- Family history:
- Ovarian or breast cancer (BRCA mutations) — relevant if complex cyst morphology raises malignancy concern [3]
- Bleeding disorders — von Willebrand disease is associated with a 52% incidence of ovarian cysts vs. 22% in controls [12]
- Endometriosis (endometrioma rupture)
- Social context: Sexual activity, contraception use, STI risk factors
7. Risk Factors
- Reproductive age — peak incidence in women 15–45 years
- Anticoagulation therapy — well-documented risk for hemorrhagic cyst rupture with significant hemoperitoneum [6-7][13]
- Bleeding disorders (von Willebrand disease, platelet dysfunction) [12]
- Ovulation induction/fertility treatments [9]
- Prior ovarian cyst or rupture history
- Corpus luteum cyst (more vascular than follicular cysts, higher hemorrhage risk) [14]
- Right ovary — most ruptures occur on the right, possibly due to proximity to the appendix and differences in venous drainage [14]
- Pregnancy — increases risk of corpus luteum rupture [14]
- No consistent association with sexual intercourse or trauma as triggers [1]
8. Differential Diagnosis
- Cannot-miss diagnoses:
- Ruptured ectopic pregnancy — always rule out with β-hCG in reproductive-age women [4][15]
- Ovarian torsion — sudden onset, intermittent pain, nausea/vomiting; enlarged edematous ovary on US [10][16]
- Appendicitis — especially right-sided cyst rupture; most common misdiagnosis [14][17]
- Other important differentials:
- Tubo-ovarian abscess — fever, vaginal discharge, cervical motion tenderness [3]
- Endometrioma rupture — history of endometriosis, "chocolate cyst" contents, chemical peritonitis
- Ruptured dermoid cyst — elevated CRP, CA-125, CA 19-9, SCC; risk of chemical peritonitis [18]
- Nephrolithiasis — flank pain radiating to groin, hematuria
- Pelvic inflammatory disease — bilateral pain, discharge, fever
- Ovarian hyperstimulation syndrome — in patients on fertility medications [9]
- Mesenteric ischemia, bowel obstruction (in older patients)
9. Past Medical History
- Prior ovarian cysts, ruptures, or ovarian surgery
- Endometriosis
- Bleeding disorders or anticoagulant use
- History of ectopic pregnancy
- Pelvic inflammatory disease or STIs
- Fertility treatments
- Cardiac conditions requiring anticoagulation (mechanical valves, atrial fibrillation) [13]
10. Physical Exam
- Vital signs: Tachycardia (often the first sign of hemorrhage), hypotension, orthostatic changes [5][11]
- Abdominal exam: Unilateral lower quadrant tenderness (may be bilateral if significant free fluid), guarding, rebound tenderness, rigidity
- Pelvic exam:
- Adnexal tenderness (unilateral)
- Cervical motion tenderness (also seen in ectopic pregnancy, PID, torsion — not specific)
- Assess for vaginal bleeding
- Palpable adnexal mass (may or may not be present)
- Concerning findings: Diffuse peritonitis, distended abdomen, pallor, diaphoresis, cool extremities
11. Lab Studies
- β-hCG (urine or serum) — mandatory in all reproductive-age women to rule out ectopic pregnancy [4]
- CBC — hemoglobin/hematocrit to assess degree of hemorrhage; initial Hgb was significantly lower in surgical vs. conservative groups (11.3 vs. 12.2 g/dL); serial monitoring recommended [19]
- Type and screen/crossmatch — if significant hemorrhage suspected
- Coagulation studies (PT/INR, aPTT) — especially in patients on anticoagulants [8]
- BMP — assess renal function, electrolytes
- Lactate — if concern for hemorrhagic shock or tissue hypoperfusion [5]
- Urinalysis — rule out UTI/nephrolithiasis
- CA-125 — not routinely needed acutely; consider if complex cyst morphology or postmenopausal patient raises malignancy concern [20]
12. Imaging
- First-line: Transvaginal ultrasound (TVUS) combined with transabdominal ultrasound — imaging modality of choice per ACR Appropriateness Criteria [21-22]
- Sensitivity of 88.2% for hemorrhagic cysts [21]
- Findings: Collapsed or irregular cyst wall, echogenic free fluid (hemoperitoneum), "ring of fire" sign on Doppler (hypervascularity of cyst wall), retracted clot
- Quantify free fluid: Posterior cul-de-sac fluid depth, presence of fluid in Morrison's pouch or paracolic gutters
- CT abdomen/pelvis with IV contrast:
- Not first-line for suspected gynecologic etiology [21]
- Useful when diagnosis uncertain, US inconclusive, or concern for non-gynecologic pathology
- Findings: Irregularly enhancing adnexal cyst with hemorrhagic free fluid, sentinel clot sign, active contrast extravasation [21][23]
- Hemoperitoneum depth >5.8 cm and active bleeding on CT are significant predictors of surgical intervention (OR 5.786 when both present) [23]
- Presence of liver-dome fluid on imaging predicts need for surgery [19]
- MRI: Reserved for indeterminate cases; 100% sensitivity for hemorrhagic cysts [21]
- Imaging unnecessary: Small, simple cysts in asymptomatic patients with known functional cyst history
13. Special Tests
- FAST exam (bedside ultrasound): Rapid identification of free fluid in the pelvis and abdomen; expedites triage in the ED [5][24]
- Culdocentesis: Historically used to confirm hemoperitoneum (positive if hematocrit >12% suggests surgical hemorrhage); largely replaced by ultrasound [14]
- Shock Index (HR/SBP): >1.0 suggests significant hemorrhage requiring aggressive resuscitation
- Predictors of surgical need: [2][19][23]
- Diastolic BP ≤70 mmHg
- Pelvic fluid depth ≥5.6 cm on CT
- Active contrast extravasation
- Liver-dome fluid on imaging
- Initial Hgb <11 g/dL
14. ECG
- Not routinely indicated for uncomplicated ovarian cyst rupture
- Obtain ECG if:
- Hemodynamically unstable (to evaluate for demand ischemia, arrhythmia)
- Significant hemorrhage with tachycardia
- Older patients or those with cardiac comorbidities
- Expected findings in hemorrhagic shock: Sinus tachycardia; ST changes may indicate demand ischemia in the setting of anemia/hypovolemia
15. Assessment
Ruptured ovarian cysts most commonly involve functional cysts (corpus luteum > follicular) in reproductive-age women. [1] The presentation is typically acute unilateral pelvic pain with variable degrees of hemoperitoneum. The condition is self-limiting in ~80–85% of cases. [1-2]
Severity stratification
- Mild: Stable vitals, minimal free fluid, pain controlled → conservative management
- Moderate: Moderate free fluid, borderline vitals, pain requiring IV analgesia → observation with serial exams and labs
- Severe: Hemodynamic instability, large hemoperitoneum, active extravasation → surgical intervention [2][19][23]
Atypical presentations: Right-sided rupture mimicking appendicitis; rupture in pregnancy mimicking ectopic; rupture on anticoagulation presenting with massive hemoperitoneum out of proportion to cyst size [7-8][14]
Complications: Hemorrhagic shock, hemoperitoneum requiring transfusion, chemical peritonitis (dermoid/endometrioma rupture), adhesion formation, recurrence [18]
16. Treatment Plan
Initial stabilization
- ABCs, two large-bore IVs, cardiac monitoring
- IV crystalloid resuscitation (NS or LR) for hemodynamic instability [11]
- Type and crossmatch; transfuse pRBCs if Hgb <7 g/dL (or <8 g/dL with cardiac disease) [11]
- Hold anticoagulants; consider reversal if life-threatening hemorrhage [11]
Conservative management (majority of cases)
- IV analgesia: Ketorolac 15–30 mg IV, opioids PRN
- Antiemetics: Ondansetron 4 mg IV
- Serial abdominal exams and vital signs q1–4h
- Serial hemoglobin monitoring (q4–6h initially)
- Bed rest, NPO if surgery possible
Surgical intervention (indications)
- Hemodynamic instability despite resuscitation
- Expanding hemoperitoneum on serial imaging
- Diastolic BP ≤70 mmHg + pelvic fluid depth ≥5.6 cm (77.8% surgical rate when both present) [2]
- Active contrast extravasation on CT [23]
- Diagnostic uncertainty (cannot exclude torsion or ectopic)
- Approach: Laparoscopy preferred; cystectomy or ovarian wedge resection with hemostasis; fertility preservation prioritized [1][3]
Recurrence prevention
- Combined oral contraceptives to suppress ovulation [10]
- In patients on anticoagulation: Progestin-only contraception (etonogestrel implant preferred) [6]
- GnRH agonists considered for refractory recurrence in anticoagulated patients [25]
17. Disposition
- Discharge criteria:
- Hemodynamically stable throughout observation
- Pain controlled with oral medications
- Stable or improving hemoglobin on serial checks
- Minimal free fluid on imaging
- Reliable follow-up arranged
- Negative pregnancy test
- Observation/admission criteria:
- Moderate hemoperitoneum requiring serial monitoring
- Borderline hemodynamics or tachycardia
- Need for IV analgesia
- Patients on anticoagulation (higher risk of ongoing hemorrhage) [26]
- Diagnostic uncertainty
- Surgical/ICU admission:
- Hemodynamic instability
- Need for transfusion
- Active extravasation on imaging
- Failed conservative management
- Specialist consultation triggers:
- OB/GYN for all cases with significant hemoperitoneum, hemodynamic instability, or diagnostic uncertainty
- Gynecologic oncology if imaging suggests malignancy [3]
- Hematology if underlying bleeding disorder suspected [12]
18. Follow Up / Return Precautions
- Follow-up timing: OB/GYN follow-up within 1–2 weeks for repeat pelvic ultrasound to confirm resolution
- Repeat imaging: Ultrasound at 6–8 weeks to ensure cyst resolution; persistent complex cysts warrant further evaluation [3-4]
- Return immediately for:
- Increasing or recurrent severe abdominal/pelvic pain
- Lightheadedness, dizziness, or fainting
- Heavy vaginal bleeding
- Fever >38°C
- Nausea/vomiting preventing oral intake
- Feeling of "passing out" or weakness
- Patient counseling:
- Most ruptured cysts resolve without long-term complications
- Functional cysts are common and often recur; discuss contraception for prevention [10]
- Expected recovery: Pain typically improves over 1–3 days; residual soreness may last 1–2 weeks
- Avoid strenuous activity for 1–2 weeks
- If on anticoagulation, discuss ovulation suppression strategies with gynecologist to prevent recurrence [6]
References
1. Trends and Outcomes of Ruptured Ovarian Cysts. — Lim WH, Woods N, Lamaro VP. Postgraduate Medical Journal. 2022.
2. Successful Conservative Management of Ruptured Ovarian Cysts With Hemoperitoneum in Healthy Women. — Kim JH, Lee SM, Lee JH, et al. PloS One. 2014.
3. Practice Bulletin No. 174: Evaluation and Management of Adnexal Masses. — Committee on Practice Bulletins—Gynecology Obstetrics and Gynecology. 2016.
4. Lesions of the Ovary and Fallopian Tube. — Sisodia RC, Del Carmen MG. The New England Journal of Medicine. 2022.
5. Hemorrhagic Shock. — Cannon JW. The New England Journal of Medicine. 2018.
6. Special Considerations for Women of Reproductive Age on Anticoagulation. — Azenkot T, Schwarz EB. Journal of General Internal Medicine. 2022.
7. Ovarian Hemorrhage Complicating Warfarin Sodium Anticoagulant Therapy. — Matseoane S, Batts JA, Mandeville EO. American Journal of Obstetrics and Gynecology. 1976.
8. Massive Ovarian Haemorrhage Complicating Oral Anticoagulation in the Antiphospholipid Syndrome: A Report of Three Cases. — Crétel E, Cacoub P, Huong DL, et al. Lupus. 1999.
9. Hemoperitoneum From Ruptured Cyst in a Hyperstimulated Ovary: A Sonographic Mimic of Ovarian Hyperstimulation Syndrome. — Gunabushanam G, Mandal K, Lal S. Journal of Clinical Ultrasound : JCU. 2007.
10. Diagnosis and Management of Ovarian Cyst Accidents. — Bottomley C, Bourne T. Best Practice & Research. Clinical Obstetrics & Gynaecology. 2009.
11. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. — Tomaselli GF, Mahaffey KW, Cuker A, et al. Journal of the American College of Cardiology. 2020.
12. Screening and Management of Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding: ACOG COMMITTEE OPINION, Number 785. — Committee on Adolescent Health Care Obstetrics and Gynecology. 2019.
13. Ovarian (Corpus Luteum) Hemorrhage During Anticoagulation Therapy. — Tresch DD, Halverson G, Blick M, Keelan MH. Annals of Internal Medicine. 1978.
14. Ruptured Corpus Luteum With Hemoperitoneum: A Study of 173 Surgical Cases. — Hallatt JG, Steele CH, Snyder M. American Journal of Obstetrics and Gynecology. 1984.
15. Does This Woman Have an Ectopic Pregnancy?The Rational Clinical Examination Systematic Review. — Crochet JR, Bastian LA, Chireau MV. The Journal of the American Medical Association. 2013.
16. Adnexal Torsion: Review of Radiologic Appearances. — Dawood MT, Naik M, Bharwani N, et al. Radiographics : A Review Publication of the Radiological Society of North America, Inc. 2021.
17. Acute Abdominal Pain in Adults: Evaluation and Diagnosis. — Yew KS, George MK, Allred HB. American Family Physician. 2023.
18. Clinical Characteristics and Laparoscopic Surgical Outcomes of Ovarian Dermoid Cysts Complicated by Spontaneous Rupture: Nine Cases and a Literature Review. — Takeda A, Koike W. The Journal of International Medical Research. 2023.
19. The Predicting Factors for Indication of Surgery in Patients With Hemoperitoneum Caused by Corpus Luteum Cyst Rupture. — Kim MJ, Kim HM, Seong WJ. Scientific Reports. 2021.
20. Adnexal Masses: Diagnosis and Management. — Wheeler V, Umstead B, Chadwick C. American Family Physician. 2023.
21. ACR Appropriateness Criteria® Acute Pelvic Pain in the Reproductive Age Group: 2023 Update. — Brook OR, Dadour JR, Robbins JB, et al. Journal of the American College of Radiology : JACR. 2024.
22. Evaluation of Acute Pelvic Pain in Women. — Frasca DJ, Jarrio CE, Perdue J. American Family Physician. 2023.
23. Ruptured Corpus Luteal Cyst: Prediction of Clinical Outcomes With CT. — Lee MS, Moon MH, Woo H, et al. Korean Journal of Radiology. 2017.
24. Ultrasound Guidelines: Emergency, Point-of-Care, and Clinical Ultrasound Guidelines in Medicine. — American College of Emergency Physicians (2023). 2023.
25. Management of Peritoneal Hemorrhage Due to Follicle Rupture Under Anticoagulation Therapy. — Ulrich U, Rossmanith WG. Journal of Endocrinological Investigation. 1994.
26. Conservative Management of Corpus Luteum Haemorrhage in Patients on Anticoagulation: A Report of Three Cases and Review of Literature. — Gupta A, Gupta S, Manaktala U, Gupta MM, Solanki V. Archives of Gynecology and Obstetrics. 2015.